Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Prime Medicine (PRME) Other Non Operating Income: 2021-2025

Historic Other Non Operating Income for Prime Medicine (PRME) over the last 4 years, with Sep 2025 value amounting to $44,000.

  • Prime Medicine's Other Non Operating Income rose 153.01% to $44,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $142,000, marking a year-over-year decrease of 2.74%. This contributed to the annual value of $41,000 for FY2024, which is 85.04% down from last year.
  • According to the latest figures from Q3 2025, Prime Medicine's Other Non Operating Income is $44,000, which was up 144.44% from $18,000 recorded in Q2 2025.
  • Over the past 5 years, Prime Medicine's Other Non Operating Income peaked at $2.1 million during Q1 2023, and registered a low of -$83,000 during Q3 2024.
  • Moreover, its 3-year median value for Other Non Operating Income was $42,000 (2024), whereas its average is $227,909.
  • As far as peak fluctuations go, Prime Medicine's Other Non Operating Income skyrocketed by 72,900.00% in 2022, and later crashed by 293.02% in 2024.
  • Quarterly analysis of 5 years shows Prime Medicine's Other Non Operating Income stood at $12,000 in 2021, then soared by 7,616.67% to $926,000 in 2022, then slumped by 84.02% to $148,000 in 2023, then slumped by 70.95% to $43,000 in 2024, then spiked by 153.01% to $44,000 in 2025.
  • Its last three reported values are $44,000 in Q3 2025, $18,000 for Q2 2025, and $37,000 during Q1 2025.